BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  MAX BioPharma announces key update on its anti-fibrotic and anti-inflammatory oxysterol drug candidate that inhibits MASH, atherosclerosis, and fat tissue inflammation

  October 25, 2024

   · 

  5 min read
• Press Releases

  Fresenius Medical Care Recent Study Validates Innovative Anemia Therapy Software Improves Clinical Outcomes for Hemodialysis Patients

  October 25, 2024

   · 

  5 min read
• Press Releases

  Evexta Bio Appoints Edith A. Perez as Scientific Advisor

  October 25, 2024

   · 

  2 min read
• Press Releases

  Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

  October 25, 2024

   · 

  15 min read
• Press Releases

  Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem

  October 25, 2024

   · 

  8 min read
• Press Releases

  Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics

  October 25, 2024

   · 

  3 min read
• Press Releases

  ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

  October 25, 2024

   · 

  9 min read
• Press Releases

  Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

  October 25, 2024

   · 

  5 min read
• Press Releases

  Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024

  October 25, 2024

   · 

  7 min read
• Press Releases

  Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024

  October 25, 2024

   · 

  5 min read